Systems and methods of the present disclosure are directed to neural stimulation via non-invasive sensory stimulation. Non-invasive sensory stimulations can comprise audio stimulation, visual stimulation, mechanical stimulation, or a combination thereof. The combination and/or sequence of one or more of audio, visual, and mechanical brain stimulations can adjust, control or otherwise manage the frequency of the neural oscillations to provide beneficial effects to one or more cognitive states or cognitive functions of the brain, while mitigating or preventing adverse consequences on a cognitive state or cognitive function that stems from, for example, sleep deprivation, stress, hormonal imbalance, or other physical, physiological, or psychological conditions. In doing so, the present systems and methods can improve the cognitive potential of a person.

A cassette including: a cartridge holder including a first end, a second end having a holder opening, and a holder columnar space located between the first end and the second end and capable of accommodating a drug cartridge, drug cartridge including: a cylinder including a first end at which an injection needle is insertable/extractable, a second end at which a cylinder opening is located, and a cylinder columnar space located between the first end and the second end; a drug placed in the cylinder columnar space; and a gasket being placed in the cylinder columnar space; a cassette cap capable of opening and closing the holder opening, the cassette cap including a first end having a cap opening that is opposed to the holder opening, a second end having a piston insertion opening, and a cap columnar space located between the first end and the second end.

The Intelligent Automatic Oxygen Therapy System provides a device that allows the automatic and intelligent dosage of the percentage of an oxygen/air gas mixture and the flow delivered to each patient through non-invasive oxygen therapy procedures, based on the analysis of several measured variables that confirm the SpO2 value before taking any action. This device allows to measure biomedical signs with the main object of monitoring the oxygen saturation (SpO2), confirming its value with the analysis of the mentioned signs according to their concordance and interrelationship with each other. The equipment through artificial intelligence detects events that can occur due to the movement or for misplaced sensors. It also keeps and analyzes the records of the patient, evaluates the alarms in an intelligent way by correlating all acquired data; with this analysis the equipment can automatically and reliably provide the oxygen/air mixture adequate for each patient, with five operation modes. It activates the processed and valid alarms in an intelligent way and informs in a timely manner to the personal staff about possible found pathologies.

An apparatus for injectate delivery includes a cartridge, a linear actuator, a rotary motor mechanically coupled the actuator, and a controller coupled to the motor. The controller controls a linear motion of the actuator by controlling an electrical input supplied to the motor in a first interval during which the motor is stationary with the linear actuator engaged with the cartridge to displace an injectate in the cartridge, a second interval following the first interval during which the controller accelerates the motor from stationary to a first speed selected to create a jet of the injectate from the cartridge with a velocity sufficient to pierce human tissue to a subcutaneous depth, a third interval during which the controller maintains the motor at or above the first speed, and a fourth interval during which the controller decelerates the motor to a second speed to deliver the injectate at the subcutaneous depth.

Devices, systems, and methods are provided herein for delivering medication (e.g., insulin) via a wearable pump having a patch-style form factor for adhesion to a user’s body. The reusable pump may be coupled to a disposable cap housing a microdosing system for delivering precise, repeatable doses of medication to a cannula configured to deliver medication to a target infusion area beneath the user’s outer skin layer. The system further may include an applicator for inserting the cannula into the user’s skin and/or applying an adhesive pad to the skin.

The present disclosure provides a medicament delivery device including a housing, a skin sensor positioned at least partially within the housing, and a transmitter positioned within the housing. The medicament delivery device is configured to determine, via the skin sensor, whether or not the medicament delivery device is attached to the skin of the user. In response to a determination that the medicament delivery device is attached to the skin of the user, the medicament delivery device prevents transmission of unique identification data associated with the medicament delivery device and/or the user from the transmitter. In response to a determination that the medicament delivery device is not attached to the skin of the user, the medicament delivery device transmits, via the transmitter, the unique identification data to one or more external receivers.

An injection device may include a housing, a container disposed within the housing, the container enclosing a fluid and having a first end and a second end, a conduit movable relative to the container, wherein the conduit is not in fluid communication with the fluid enclosed by the container while in a first position, and is in fluid communication with the fluid enclosed by the container and configured to deliver the fluid from the container to a patient while in a second position, and a lock that is removable from the housing, the lock having a first portion and a second portion.

The invention relates to an aerosol delivery device (10) comprising an aerosol generator (3) for generating an aerosol in the aerosol delivery device (10), a sensor (5) configured to detect a use of the aerosol delivery device (10) for aerosol treatment, and a controller (7) configured to deactivate the aerosol generator (3) if no use of the aerosol delivery device (10) for aerosol treatment is detected by the sensor (5). Further, the invention relates to a method for operating an aerosol delivery device (10), comprising the steps of operating an aerosol generator (3) for generating an aerosol in the aerosol delivery device (10), detecting a use of the aerosol delivery device (10) for aerosol treatment by means of a sensor (5), and deactivating the aerosol generator (3) by means of a controller (7) if no use of the aerosol delivery device (10) for aerosol treatment is detected by the sensor (5).

A system includes a converter configured to electrically couple to a power source and to a heating element of a vaporizer atomizer. The converter can be further configured to receive a first voltage from the power source and provide a second voltage to the heating element. The converter can be a direct-current to direct-current converter. A power monitor configured to electrically couple to the heating element, measure a current through the heating element, measure a voltage over the heating element, calculate a power and/or resistance, and output a control signal to the converter. The converter can be configured to be controlled by the control signal to vary the second voltage to maintain a target power or a target temperature over the heating element. Related apparatus, systems, techniques and articles are also described.

A drug delivery device includes a container for storing a drug, the container having a stopper for expelling the drug; an injection drive comprising an energy source for directly or indirectly acting on the stopper to expel the drug; a sensor for detecting contact between the drug delivery device and a body of a patient; and a user interface (UI) for activating or causing the activation of the injection drive. The device is operative for drawing attention to the UI, if the sensor detects contact between the drug delivery device and the body of the patient, to thereby indicate that the injection drive is ready to be activated, which activation is the next step in the drug administration process.